DIVI'S LABORATORIES LTD. - 532488 - Intimation Of Commencement Of Commercial Production From DCV-SEZ Unit
This is to inform that the Company has commenced commercial production effective from 09 March, 2020 from DCV-SEZ Unit of the Company at Chippada Village, Bheemunipatnam Mandal, Visakhapatnam. This is for your information and records. Divis Laboratories Ltd - 532488 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Divis Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Divis Laboratories Ltd - 532488 - Declaration Of Postal Ballot Results
With respect to the Postal Ballot Notice dated 04 January, 2020, we are submitting herewith the results of the Postal Ballot declared today (i.e. on 27 February, 2020) along with the copy of the report issued by the Scrutinizer, Mr. V. Bhaskara Rao, Company Secretary in Practice. Members have approved the aforementioned resolutions with requisite majority. Accordingly, the resolutions mentioned in the said Postal Ballot Notice shall be deemed to have been passed on 26 February, 2020 i.e., the last date specified for receipt of duly completed postal ballot forms or e-voting. This is for your information and records.
Buy Divis Laboratories target of Rs 2430: Sharekhan
Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 2430 in its research report dated February 20, 2020. Divis Laboratories Ltd - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of newspaper advertisement regarding notice of record date for interim dividend of Rs. 16/- (Rupees Sixteen only) per equity share of Rs. 2/- each for the financial year 2019-20 as declared by the Board of Directors of the Company at its meeting held on 12 February, 2020. This notice is published in the following newspapers on 13 February, 2020: Financial Express (English Daily) Andhra Prabha (Telugu Daily) Copy of the advertisement is also available on the website of the Company www.divislabs.com Divis Laboratories Ltd - 532488 - Board declares Interim Dividend
Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 12, 2020, inter alia, has declared an Interim Dividend of Rs. 16/- (Rupees Sixteen Only) per equity share of Rs. 2/- each for the financial year 2019-20.The payment of the interim dividend would be made to the eligible shareholders on or before March 05, 2020. DIVI'S LABORATORIES LTD. - 532488 - Intimation Of Record Date For Interim Dividend
We hereby inform that the Board of Directors of the Company at its meeting held 12 February, 2020 declared an Interim Dividend of Rs. 16/- (Rupees Sixteen Only) per equity share of Rs. 2/- each for the financial year 2019-20. Further, the Board of Directors of the Company has fixed the Record Date as Wednesday, 26 February, 2020 to determine the names of the equity shareholders, who shall be entitled to receive payment towards Interim Dividend of the Company for the financial year 2019-20 declared at the Board Meeting held on 12 February, 2020. The payment of the interim dividend would be made to the eligible shareholders on or before 05 March, 2020. The Board meeting commenced at 15.00 Hrs and concluded at 16.20 Hrs. This is for your information and records. DIVI'S LABORATORIES LTD. - 532488 - Outcome Of Board Meeting Held On 12 February, 2020 - Declaration Of Interim Dividend
We hereby inform that the Board of Directors of the Company at its meeting held 12 February, 2020 declared an Interim Dividend of Rs. 16/- (Rupees Sixteen Only) per equity share of Rs. 2/- each for the financial year 2019-20. Further, the Board of Directors of the Company has fixed the Record Date as Wednesday, 26 February, 2020 to determine the names of the equity shareholders, who shall be entitled to receive payment towards Interim Dividend of the Company for the financial year 2019-20 declared at the Board Meeting held on 12 February, 2020. The payment of the interim dividend would be made to the eligible shareholders on or before 05 March, 2020. The Board meeting commenced at 15.00 Hrs and concluded at 16.20 Hrs. DIVI'S LABORATORIES LTD. - 532488 - Closure of Trading Window
Pursuant to Regulation 29 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby inform that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday, 12 February, 2020, inter-alia, to consider declaration of Interim Dividend, if any, on the equity shares of the Company, for the Financial Year 2019-2020. This is to inform that, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders and Designated Persons, the Trading Window for dealing in securities of the Company shall remain closed for all Designated Persons and their immediate relatives from 07 February, 2020 to 14 February, 2020 (inclusive of both days). The trading window will re-open from 15 February, 2020. This is for your information and records. DIVI'S LABORATORIES LTD. - 532488 - Board Meeting Intimation for Inter-Alia, Considering Declaration Of Interim Dividend, If Any, On The Equity Shares Of The Company, For The Financial Year 2019-2020.
DIVI''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby inform that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday, 12 February, 2020, inter-alia, to consider declaration of Interim Dividend, if any, on the equity shares of the Company, for the Financial Year 2019-2020. This is to inform that, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders and Designated Persons, the Trading Window for dealing in securities of the Company shall remain closed for all Designated Persons and their immediate relatives from 07 February, 2020 to 14 February, 2020 (inclusive of both days). The trading window will re-open from 15 February, 2020. This is for your information and records.